Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001655016-25-000007

Director bought 10,700 shares at $18.64 ($199,403)

From the SEC's structured data for this filing

Trades in this filing

Fox Jonathan C · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-11 Purchase : show line 1 in the form +10,700 $18.64 $199,403 23,702 D
Open-market purchases · 10,700 sh · avg $18.64 · $199,403
Loading xslF345X05/primarydocument.xml…